These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Dose-dependent inactivation of extracellular human immunodeficiency virus by miramistin]. Krivorutchenko IuL Vopr Virusol; 1998; 43(3):122-4. PubMed ID: 9702810 [TBL] [Abstract][Full Text] [Related]
5. [Prospects of using miramistin for individual prevention of sexual HIV transmission]. Krivorutchenko IuL; Andronovskaia IB Lik Sprava; 2013 Mar; (2):117-23. PubMed ID: 24605621 [TBL] [Abstract][Full Text] [Related]
6. [In vitro study of antiviral activity of Myramistin against measles and mumps viruses]. Agafonov AP; Ignat'ev GM; Svistov VV; Smirnov IV; Krivoshein IuS Antibiot Khimioter; 2005; 50(5-6):17-9. PubMed ID: 16526604 [TBL] [Abstract][Full Text] [Related]
7. [In vitro study of antiviral activity of Myramistin against subtypes H3N2 and H5N1 of influenza virus]. Agafonov AP; Skarnovich MO; Petrishchenko VA; Shishkina LN; Sergeev AN; Svistov VV; Smirnov IV; Kirichenko NA; Krivoshein IuS Antibiot Khimioter; 2005; 50(12):9-11. PubMed ID: 19140480 [TBL] [Abstract][Full Text] [Related]
8. Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production. Shoji S; Furuishi K; Misumi S; Miyazaki T; Kino M; Yamataka K Biochem Biophys Res Commun; 1994 Nov; 205(1):967-75. PubMed ID: 7999140 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents. Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties. Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320 [TBL] [Abstract][Full Text] [Related]
11. A novel assay system for anti-human immunodeficiency virus type 1 (HIV-1) activity using a subclone of a monocytic cell line, U937. Miyano-Kurosaki N; Nakashima H; Ichiyama K; Inazawa K; Tabata H; Tanabe H; Ohnishi K; Mizusawa H; Ohshiro Y; Yamamoto N Microbiol Immunol; 1994; 38(10):813-8. PubMed ID: 7869961 [TBL] [Abstract][Full Text] [Related]
13. Anti-Tat MTT assay: a novel anti-HIV drug screening system using the viral regulatory network of replication. Kira T; Merin JP; Baba M; Shigeta S; Okamoto T AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1359-66. PubMed ID: 8573393 [TBL] [Abstract][Full Text] [Related]
14. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells. Prochaska HJ; Rubinson L; Yeh Y; Baron P; Polsky B Mol Pharmacol; 1994 May; 45(5):916-21. PubMed ID: 8190108 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection. Murray MF; Srinivasan A Biochem Biophys Res Commun; 1995 May; 210(3):954-9. PubMed ID: 7763268 [TBL] [Abstract][Full Text] [Related]
16. Differential in vitro anti-HIV activity of natural lignans. Schröder HC; Merz H; Steffen R; Müller WE; Sarin PS; Trumm S; Schulz J; Eich E Z Naturforsch C J Biosci; 1990; 45(11-12):1215-21. PubMed ID: 1965681 [TBL] [Abstract][Full Text] [Related]
17. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells. Weichold FF; Lisziewicz J; Zeman RA; Nerurkar LS; Agrawal S; Reitz MS; Gallo RC AIDS Res Hum Retroviruses; 1995 Jul; 11(7):863-7. PubMed ID: 7546914 [TBL] [Abstract][Full Text] [Related]
18. [The depression of the reproduction of the human immunodeficiency virus by the use of Bogomolets antireticular cytotoxic serum]. Spivak MIa; Karpov OV; Antonenko SV; Barbasheva OV; Kvielienkova KI; Voloshchenko IuV Mikrobiol Z; 1997; 59(5):57-61. PubMed ID: 9480019 [TBL] [Abstract][Full Text] [Related]
19. Effect of lignins on HIV-induced cytopathogenicity and myeloperoxidase activity in human myelogenous leukemic cell lines. Kunisada T; Sakagami H; Takeda M; Naoe T; Kawazoe Y; Ushijima H; Müller WE; Kitamura T Anticancer Res; 1992; 12(6B):2225-8. PubMed ID: 1338279 [TBL] [Abstract][Full Text] [Related]